Cordium Pharmaceuticals Pvt Ltd is a reliable India-based pharmaceutical exporter specializing in high-quality Pomalidomide 1mg, 2mg, and 4mg capsules for regulated international markets. We supply WHO-GMP certified oncology formulations with consistent quality, compliance, and timely global distribution.
š¬ What is Pomalidomide? (Key Pharmaceutical Insight)
Pomalidomide is a third-generation immunomodulatory drug (IMiD) widely used in hematology-oncology therapies, particularly in relapsed and refractory multiple myeloma management under specialist supervision.
š¢ Pomalidomide Export Strength ā India to Global Markets
We are actively exporting Pomalidomide capsules (1mg / 2mg / 4mg) across regulated and semi-regulated markets including:
š Export Destinations
š°šŖ Kenya
š³š¬ Nigeria
š¬š Ghana
šµš Philippines
š»š³ Vietnam
š¦šŖ United Arab Emirates
šøš¦ Saudi Arabia
šŗšæ Uzbekistan
š°šæ Kazakhstan
šŗšø United States
š¬š§ United Kingdom
šæš¦ South Africa
š Product Highlights
Available strengths: 1mg, 2mg, 4mg capsules
Manufactured under WHO-GMP certified facilities
Strict quality assurance & regulatory compliance
Export-grade packaging and cold-chain safety standards (where applicable)
Stable formulation suitable for global oncology supply chains
š§¬ Why Choose Cordium Pharmaceuticals Pvt Ltd?
š®š³ Leading Indian pharmaceutical exporter
š Strong presence in Africa, Asia, GCC, Europe & USA
š¦ Bulk supply capability for institutional and government tenders
š Complete export documentation support (COA, COI, MSDS)
ā” Fast logistics and reliable international shipping network
š Global Pharma Supply Partner for Oncology Medicines
With rising global demand for cost-effective oncology treatments, India continues to be a key hub for pharmaceutical exports. Cordium Pharmaceuticals Pvt Ltd ensures a dependable supply chain for Pomalidomide capsules across regulated and emerging markets worldwide.
š© Business Inquiry
For bulk export orders, distribution partnerships, or regulatory dossiers, connect with our export team for country-specific compliance and pricing support.
š¬ What is Pomalidomide? (Key Pharmaceutical Insight)
Pomalidomide is a third-generation immunomodulatory drug (IMiD) widely used in hematology-oncology therapies, particularly in relapsed and refractory multiple myeloma management under specialist supervision.
š¢ Pomalidomide Export Strength ā India to Global Markets
We are actively exporting Pomalidomide capsules (1mg / 2mg / 4mg) across regulated and semi-regulated markets including:
š Export Destinations
š°šŖ Kenya
š³š¬ Nigeria
š¬š Ghana
šµš Philippines
š»š³ Vietnam
š¦šŖ United Arab Emirates
šøš¦ Saudi Arabia
šŗšæ Uzbekistan
š°šæ Kazakhstan
šŗšø United States
š¬š§ United Kingdom
šæš¦ South Africa
š Product Highlights
Available strengths: 1mg, 2mg, 4mg capsules
Manufactured under WHO-GMP certified facilities
Strict quality assurance & regulatory compliance
Export-grade packaging and cold-chain safety standards (where applicable)
Stable formulation suitable for global oncology supply chains
š§¬ Why Choose Cordium Pharmaceuticals Pvt Ltd?
š®š³ Leading Indian pharmaceutical exporter
š Strong presence in Africa, Asia, GCC, Europe & USA
š¦ Bulk supply capability for institutional and government tenders
š Complete export documentation support (COA, COI, MSDS)
ā” Fast logistics and reliable international shipping network
š Global Pharma Supply Partner for Oncology Medicines
With rising global demand for cost-effective oncology treatments, India continues to be a key hub for pharmaceutical exports. Cordium Pharmaceuticals Pvt Ltd ensures a dependable supply chain for Pomalidomide capsules across regulated and emerging markets worldwide.
š© Business Inquiry
For bulk export orders, distribution partnerships, or regulatory dossiers, connect with our export team for country-specific compliance and pricing support.
Keywords
